Home / Transcripts / FutureFuel Corp. (FF) · August 11, 2026

FutureFuel Corp. (FF) Earnings Call Transcript

August 11, 2026

New York Stock Exchange US Energy Oil, Gas and Consumable Fuels earnings 42 min

Earnings Call Speaker Segments

Rose Sparks executive
#1

Thanks, and good morning everyone, and welcome to FutureFuel's Second Quarter 2026 Results Conference Call. With us today are our Chairman and CEO, Roeland Polet, and I'm Rose Sparks, the company's Chief Financial Officer. Yesterday, after U.S. trading closed, we put out a press release that details our operational and financial results for the second quarter; that release is publicly available in the Investor Relations section of our corporate website at www.futurefuelcorporation.com. I'd like to remind you that management's commentary and responses to questions during today's conference call may include forward-looking statements, which by their nature are uncertain and outside the company's control. While these forward-looking statements reflect management's current expectations and beliefs, actual results could differ materially. For a discussion of some of the factors that could cause actual results to differ, please refer to the Risk Factors section of our latest reports filed with the SEC. Also, please note that reconciliations of all historical non-GAAP financial measures mentioned on this call can be found in the press release issued this morning. Today's call will start with prepared remarks from Roeland Polet, who will give a business update, followed by my review of our second quarter financial performance. Once these prepared remarks conclude, we will open the line for questions; with that, I'll turn the call over to Roeland.

Roeland Polet executive
#2

Thank you, Rose, and good morning to all of you. We appreciate you being on the call with us today. I'm Roeland Polet, Chairman and Chief Executive Officer of FutureFuel, once more. I came to this company close to 2 years back, after spending over 35 years in the specialty chemicals sector, and that included senior leadership positions with global manufacturers like Valspar, Celanese and DSM Firmenich. From the time I came aboard at Future Fuel in late 2024, it's been my privilege to work side by side with a workforce of more than 500 committed people to get this business ready for a fresh chapter of profitable growth and long-term value creation. During this stretch, we've made the company's foundation sturdier, honed our strategic priorities, and put together a clear road map for what lies ahead, and I'll get into that in more detail today. This marks FutureFuel's quarterly results conference call with investors in more than a decade. So with that in mind, what I have to say today amounts to a reintroduction of the company: who we are, what it is we do, the ways in which we stand apart competitively, and the opportunities we see for creating meaningful shareholder value over time. Looking ahead, our leadership team is dedicated to giving shareholders more access, transparency and insight into our business. Reinstating these quarterly calls with investors is an important part of that pledge and demonstrates our desire to interact with the investment community on a more regular basis. Having said that, and given that this marks our inaugural call together, we should begin with a broad-level look at our operations for those of you who may not know us yet. FutureFuel is a U.S.-based manufacturer entirely, operating through two separate segments: specialty chemicals and biofuels, and each is supported by our manufacturing site of about 2,200 acres in Basile, Arkansas, where product development, engineering, and commercial production are united on a single integrated campus. The Batesville facility has hosted sophisticated chemical production for roughly five decades. It represents a well-established operational base that would be hard to duplicate today, considering scale, permitting, and the complexity of production units. Within our Chemicals segment, we concentrate on two main areas: manufacturing custom chemicals on behalf of third parties, and producing proprietary specialty chemicals. On the custom side, we work hand in hand with customers to scale up and commercially manufacture specialized products through long-term production agreements. Our proprietary portfolio consists of formulations we create using our own intellectual property, which are then sold across a range of applications. Across our chemicals operations, total production capacity is about 250 million pounds each year. Within our biofuel operation, we produce biodiesel at the very same Batesville site, and that facility holds about 60 million gallons per year of biodiesel capacity. A major advantage of this operation is the wide choice of feedstocks available to us, which allows us to fine-tune the economics of production. Biodiesel's economics differ from those of our Specialty Chemicals segments and are driven more by commodity markets and regulatory factors, yet the biofuel segment serves as a complementary piece alongside our core focus on specialty chemicals that serves the future, makes the most of the Batesville complex, and helps us achieve economies of scale. Let me now walk you through the qualities that set our offering apart and explain why we outperform competitors in the markets we serve. Our greatest advantage lies in the scale, integration, and technical capabilities of the Batesville complex. A chemicals customer who comes to us receives an integrated single site that provides cutting-edge laboratories, engineering support, adaptable manufacturing units, wastewater treatment, logistics infrastructure, formats, and skilled technical teams. Through our platform, customers are able to move from development to commercial production with fewer transitions, less execution risk, and manufacturing choices that use capital more efficiently; we provide a one-stop shop solution that is difficult to duplicate within the continental United States, and this makes us an appealing <<inaudible>> play for chemicals customers looking to avoid the supply chain risk involved in sourcing key formulations from overseas partners. While the Batesville asset integration is a big attraction on its own for customers, another crucial element of the overall value proposition is our deep technical know-how and our experienced, skilled workforce. Our teams in Batesville have handled production, raw material sourcing, production quality, and formulation consistency for both batch and continuous processes; we've built a solid reputation as the go-to production partner for complex, technically demanding programs that customers might not be able to manufacture efficiently on their own. As for what we offer, it's all about lowering technical, operational, and supply chain risk for the customer. A typical relationship begins when a customer brings us a molecule, process, or manufacturing challenge. After that, we assess the chemistry, what safety standards apply, whether the production makes economic sense, and what equipment is required — then we move through development and scaling up prior to starting commercial output. When we show that value is being delivered, the partnership can grow via higher volumes, extended contract terms, additional products, or capacity that the customer pays for, since switching manufacturers may bring requalification, audits, process transfers, and production risk. Customer programs frequently span multiple years, which builds lasting stickiness across our customer base. Along those lines, our top customers had an average relationship length in 2025 of over 15 to 20 years, underscoring how long-term and sticky those customer relationships are. Before I take you through what lies ahead for FutureFuel, I want to give some context on the difficulties we encountered across the past several years — how we addressed them, and why we feel enthusiastic about the organization's future. During the years prior to 2026, three main factors affected how we operated and how we performed financially: planned and production reliability, regulatory certainty regarding biofuels economics, and elevated costs for raw material inputs. Starting with planned liability: across the last 2 years, we have made progress in improving the plant process, strengthening site safety, and achieving greater site utilization by carrying out a number of high-impact capital projects. I'll get to this in a moment, but first I want to say that we're feeling good about how Batesville's utilization has picked up during the first six months of the year. Now, turning to regulation: in March of 2026, the EPA released a new set of 2 RFS volume mandates, and that gave both us and the broader biofuels industry a much-needed boost. Under those fresh mandates, blending requirements are now the highest the program has ever seen, with a target of a 60% increase relative to 2025. Reaching the 2027 volume targets will likely require U.S. domestic biofuels production to operate at full capacity, and we see that as a tailwind for us. Also, in the first quarter of 2026, the U.S. New regulations from the Treasury Department and the Internal Revenue Service provide broader guidance on the 45Z credit and fold in modifications made by the 2025 budget Reconciliation Act. Under that rule, the SAF tax credit drops from $1.75 per gallon to $1 per gallon starting January 1, 2026, which should help put biodiesel on more equal footing. Feedstocks must originate in North America, the same requirement applies to biomass-based diesel, and the 45Z credit gains an additional 2 years, running through the end of 2029. Rose will explain shortly how this benefits our business model. Finally, even though we've seen big gains in both plant reliability and the regulatory landscape, input costs for raw materials remain high, and that's still something we're watching closely. Looking ahead, our road map for creating value is built on three main pillars: growing commercially, achieving operational excellence, and allocating capital with returns as the central focus.

Roeland Polet executive
#3

In our commercial growth pillar, the top priority is raising penetration at key existing accounts and scaling production volumes throughout the Batesville complex. Our focus is on growing the specialty chemicals pipeline, moving development products into commercial production, and locking in additional volumes from customers we already serve. We'll also go after new customer manufacturing contracts and take our proprietary chemicals portfolio into adjacent products and end markets, since our technical capabilities and existing infrastructure give us a clear edge. That said, we aren't just chasing volume for its own sake. Our aim is to pursue programs that speed our shift toward a higher value-add sales mix, so we capture steady margin improvement within durable, recurring revenue streams. By applying stricter commercial discipline, our resources can be steered toward the customers and opportunities best positioned to produce profitable growth throughout the cycle. Under our operational excellence pillar, efforts will target better cost efficiency, utilization, safety and reliability throughout the Batesville complex. Greater sales volumes generate value only when we can make them safely, consistently and at a suitable unit cost. We are therefore concentrating on plant reliability, production, scheduling, procurement, energy efficiency, maintenance practices and process productivity. We also plan to make operating performance more measurable and transparent by tracking metrics like capacity utilization, plant uptime, safety performance and unit product costs, so that we can and will spot improvement opportunities and hold the organization accountable for delivering better results. Finally, on our capital allocation pillar, organic reinvestment stays the top priority where products are backed by identifiable customer demand, including contractual commitments. Where it makes sense, we'll keep pursuing customer-funded capacity expansions while strengthening long-term commercial relationships. We'll also assess complementary acquisitions, especially opportunities to add intellectual property, proprietary products or specialized capabilities that fit into our Batesville platform. Any acquisition will bolster our competitive position and satisfy disciplined financial return requirements. Apart from putting money back into the business and making acquisitions, we will continue to assess cash dividends and buybacks of shares when opportunities arise, as part of a balanced strategy for returning capital to shareholders. All together, each element of our strategic roadmap is built to produce greater sales volumes, more efficient operations and stronger returns on invested capital. Through selective growth, more efficient operations and disciplined capital allocation, our aim is to deliver more consistent earnings, cash generation and long-term shareholder value. Now let's turn to a review of our second quarter results. For FutureFuel, the second quarter represented a return to profitable growth, with that performance fueled by strengthening end market demand, improved production economics, continued cost discipline and better optimization of our Batesville plant. Strategically, our top priority stays on maintaining safe and dependable operations throughout the company, even as we keep seeking customer co-investment for added capacity and capabilities. That effort supports our aim of speeding up growth further in the core markets we serve for specialty chemical contract manufacturing. As we said previously, we still expect to achieve positive adjusted EBITDA for the entire 2026 year. On the operational side, total production rose 26% versus a year earlier in the second quarter, driven by demand growth that was broad-based across both our specialty chemicals and biofuels end markets. Every one of those segments turned a positive gross profit on each unit sold during the quarter, and as we move into the back half of 2026, both continue to demonstrate healthy operational momentum. Total Chemical segment output climbed 34% year over year in Q2, driven by higher demand across energy and industrial end markets that powered broad-based gains in both performance chemical manufacturing and custom chemical manufacturing. Second-quarter Chemicals gross profit reached $5 million, up from $1.1 million in the prior-year period, reflecting improved volume throughput and stronger margin realization. For the Fire Fuel segment, output during the second quarter rose 21% compared with the same period a year earlier, and that held true despite a biodiesel plant being out of service for over three weeks in that stretch, since more predictable rules plus renewable fuel output requirements set for 2026 and 2027 encouraged domestic manufacturing. Gross profit for biofuels came to $10.1 million in the second quarter, compared with a gross loss of $13.5 million a year earlier, a swing that mirrored stronger plant reliability, greater throughput and better production economics, among them a timing advantage related to ongoing biofuel hedging activities. Biodiesel output from our operations continues to climb, and we expect third quarter production rates to exceed second quarter levels. Looking ahead, we continue to see strong demand in both our chemicals and biofuel segment. Even though higher input costs may persist as a near-term headwind for the business, we believe our fully domestic production footprint, extensive technical know-how in specialty chemical manufacturing, capital-light approach to growth, and long-standing collaborations with world-class customers leave us well positioned for continued positive momentum. With that, I'll hand the call over to Rose for her prepared remarks.

Rose Sparks executive
#4

Thanks, Roeland, and good morning once more to everyone joining us. I'll give you a high-level look today at how we performed financially in the second quarter, and I'll also cover our balance sheet and liquidity position as of quarter end. One thing to keep in mind: prior year comparisons have been adjusted so they conform to the weighted average method of inventory costing that the company adopted on January 1, 2026. Revenue for the second quarter of 2026 came in at $78.7 million, which is up 120.7% from $35.7 million in the second quarter of 2025. That revenue growth came from higher throughput, a better revenue volume mix, and higher average pricing across both the chemical and biofuel segments. In the second quarter of 2026, our volume rose 40.4% overall, while the average blended price we realized climbed 80.2%. Gross profit for that quarter came to $15 million, versus a gross loss of $12.4 million in the second quarter of 2025. Within second quarter gross profit, we saw a $9.1 million benefit from selling physical inventory at prices above hedge levels, and that benefit completely offset the $9.1 million in realized derivative losses we recognized during the first quarter of 2026. Gross profit additionally got a boost from $3.2 million of unrealized derivative gains in the second quarter of 2026. Leaving aside derivative effects, the gross profit gain compared with a year earlier was driven by larger volumes and stronger pricing in both the chemicals and biofuel businesses. For the second quarter of 2026, net income reached $11.4 million, whereas the second quarter of 2025 produced a net loss of $14.2 million. Adjusted EBITDA totaled $11.8 million in the second quarter of 2026, against a loss of $11.4 million in the second quarter of 2025. Turning now to the Chemical segment: revenue for that segment increased $25.8 million in the second quarter of 2026, compared with $16.6 million in the second quarter of 2025. Volume product mix effects contributed a 49% gain, and higher average prices added a 6% benefit — those were the primary factors. In Custom Chemical, revenue rose $18.5 million during the second quarter, marking a 30% jump from $14.3 million a year earlier, driven largely by greater volumes of products sold to energy customers. Performance Chemical revenue came to $7.3 million in the second quarter, compared with $2.4 million last year, chiefly owing to higher volumes for a new customer whose production began in the fourth quarter of 2025. Gross profit for the Chemical segment reached $5 million in the second quarter of 2026, an improvement over $1.1 million in the second quarter of 2025. That gain was driven by larger sales volumes in energy, which included revenue from a new product launched in Q4 2025, plus better fixed-cost absorption thanks to higher biofuel volumes. Conditions in Chemicals continued to strengthen through Q2, reflected in improved capacity utilization, stronger pricing, and a project pipeline that keeps expanding. Chemical production capacity overall is up 12% across the last twelve months, and we expect operating leverage to keep improving as output rises beyond current levels. Capacity utilization for the Chemical segment reached 65% in Q2 2026, compared with 54% in the same period last year. In the second quarter of 2026, revenue for our Biofuel segment rose to $52.9 million, up from $19.1 million during the same quarter a year earlier. The increase was driven primarily by clearer regulatory guidance on the clean fuel production credit as well as record-high RVO levels. Biofuel segment gross profit for the second quarter of 2026 came in at $10.1 million, compared with a gross loss of $13.5 million in the prior-year period — a significant improvement propelled by larger sales volumes and better price realization, even as we continue to gain from considerable feedstock optionality and elevated input costs that partially offset the favorable pricing conditions for finished products. We already told you about a $9 million hedging loss that we booked in the first quarter of 2026, and the second quarter numbers show a gain of roughly the same size, since the physical inventory behind those hedges was sold and the hedging costs we had recognized earlier came back. Conditions in the Biofuel segment continued to get better through the second quarter of 2026, helped by a supportive regulatory backdrop. Biofuel capacity utilization climbed to 56% in the second quarter, and with more regulatory clarity now, sales volumes ought to rise further in the second half of 2026. Costs for soybean oil and the other feedstocks we use to make biofuels are still high, and we expect that to keep weighing on Biofuels gross profit per gallon sold in the near term. Now moving on to cash flow, our balance sheet, and liquidity. For Q2 2026, operations generated net cash of $18.8 million, versus $5.2 million during the same period last year. Capex in the second quarter totaled $8 million, which breaks down into $2.9 million for maintenance-related spending and $5.1 million for discretionary programs. Across the first six months of 2026, capital expenditures reached $13.4 million, split between $4.1 million on maintenance and $9.3 million on discretionary programs. Within those discretionary capex figures, approximately $1.9 million in Q2 and $3.5 million for the six-month period were customer-funded investments supporting capacity expansions and new customer programs. By the end of June 30, 2026, total cash and cash equivalents stood at $34.3 million for the company, compared with $22.4 million on March 31, 2026, along with a $35 million revolving credit facility that had no borrowings outstanding. The increase in total cash from the first quarter of 2026 to the second quarter of 2026 reflected the operating profit reported for the second quarter of 2026 and customer funding tied to a custom chemical contract, partially offset by higher working capital needs stemming from new program activity and capital expenditures made to support growth. During Q2, we entered into an agreement lasting four years with an outside party to monetize Section 45Z clean fuel production credits as well as small producer tax credits — something that aligns with our continued focus on strengthening the balance sheet. For the second half of 2026, we expect gross proceeds totaling $22 million from those credit monetizations, with approximately $3 million arriving in Q3 and $19 million in Q4. That concludes our prepared remarks. Operator, we're now ready for questions in the Q&A portion of the call.

Jeff Grampp analyst
#5

Roeland, I'd like to pick up on a few things you mentioned about the improvements in plant performance and how making that a priority has mattered to your team over these last couple of years. Could you give us some context — perhaps by way of a baseball game's innings, or any comparison that suits you — as in, where are we in that improvement cycle? Have we reached the point you're aiming for today? Are more optimization efforts still ahead? Some context there would help.

Roeland Polet executive
#6

Yes. That's good. Right, Jeff, soccer is my sport. We're kind of in first-half stoppage time here, and the second half hasn't even started yet. Let me pull back for a second. In Batesville, we've got about $1 billion in invested replacement value assets. That's a big site with big capabilities and big infrastructure backing those capabilities. So we decided to put money into the infrastructure around our site — wastewater treatment, chemical incineration, every asset required, plus the nitrogen we need, to keep the plant and the site running. On top of that, the site holds plenty of manufacturing cells that our customers placed here, and those need support. Look, I don't follow baseball, so I can't speak to innings—but I'd put us roughly 60%, maybe 60% to 70%, of the way through tackling the most critical infrastructure, making certain it's secure and reliable. After that, our focus shifts to putting money into efficiency. We've got a set of projects ranked by the returns they'd deliver, and we'll put capital behind those to capture additional efficiencies—operational efficiencies—within the plant.

Jeff Grampp analyst
#7

Understood. Those details were useful. Then for my follow-up, regarding 45Z monetization, I'd like some clarification: does the agreement you discussed in the release essentially cover all of your expected 45Z generation through 2029? Is there further monetization still to be done? And could you give any clarity, I suppose, on the amount of monetization across that contract period?

Rose Sparks executive
#8

The figure we quoted covers 2026 and 2025. So roughly $3 million was cashed in Q3, and then an additional $19 million on a gross basis will be cashed in December of this year. So that is an annual monetization that will happen each year as we produce product and sell it.

Jason Tilchen analyst
#9

Congratulations on the impressive numbers, and thanks for holding the first call in quite a while. It's a privilege to be on it. One item I was wondering about: you brought up focusing on certain very niche, complex, hazardous chemistries that perhaps others aren't willing or able to make on-site. Could you say more about the core competencies that let you take on such projects safely and in compliance? And in what ways, whether through pricing or long-term relationships, do you manage to capture value from those capabilities?

Roeland Polet executive
#10

Yes. And once more, many thanks for joining the call. Our history stretches back to — not to take you back too far — but stretches back to the codec days; and this plant produced photographic chemicals and was also built to make, roughly, precursors for the pharmaceutical sector; so it has a long history, and it held permits to run very complex chemistries and, in some cases, hazardous chemistries. This was also the site where all chemistries for later on Eastman — every chemistry — was proven here and tested here to confirm it could be run, and we have extensive facilities for that, to be run at the Eastman plant and now at the future fuel plant; so it has a track record of being permitted to run complex, hazardous chemistries. There is considerable permit headroom. The equipment that went in — and we've since reinvested heavily in much of that equipment — was installed to handle those complex chemistries. And we sit on 2,200 acres in the middle of Arkansas, where we hold the permit capability, and we have the ability to expand still further to drive it. But it truly traces back to our history as a plant purpose-built to make complex chemistries; and then let me add one point to that: because we're in the middle of Arkansas, we are extremely self-contained; so we have everything we need right here. We also have the R&D department, the testing department; we have everything required to support that production.

Jason Tilchen analyst
#11

Thanks — that review is genuinely useful. In the release and the prepared remarks, you mentioned a deal with one of your customers to fund an investment of more than $40 million across the next 3 years in support of incremental capacity. I'm curious whether you could share a little more on how that relationship has developed? And does that customer sit among those 15, 20 relationships, or is it perhaps somewhat newer? Then, more broadly, are there other opportunities of this kind that you're currently evaluating? And if so, do those have to happen one after another — can multiple projects similar to this be pursued at the same time? We'd really welcome any kind of color on that.

Roeland Polet executive
#12

Yeah, those are excellent questions. So, thinking about how our business model works — we're in biodiesel, and we also operate in chemicals, correct? Within our chemicals division, we produce certain proprietary chemicals for internal use and for sale, yet contract manufacturing accounts for most of that segment's activity. Customers construct facilities on our property, operating under our permits and benefiting from chemical incineration plus oversized wastewater treatment capacity and similar assets. We refer to these as plants, though in practice they are fairly small production cells that customers build at our location, leveraging the infrastructure already present there. That approach reduces their capital expense and gives them access to the intricate, hazardous chemistry expertise we possess. That, then, is how our business model works. We mentioned an expansion underway—capacity is being increased by two or three times through it. That said, this is the model we use with other customers too. We therefore have an extensive and solid lineup of customer-product pairings, and for those we are currently in engineering stages to carry out construction of plants at our site, which we will afterward run for those customers; in chemicals, that is precisely what our business model is.

Jason Tilchen analyst
#13

All right, that's very clear. Just one final question from my side. Your guidance points to positive adjusted EBITDA in 2026. Suppose we jump ahead 6 or 7 months and you're discussing your full year results. Are there a couple of factors, whether positive or negative, that if results land above or below expectations, would be the main items you can already identify that would push things either above or below expectations?

Roeland Polet executive
#14

Yes. Naturally, we aren’t immune to economic events or economic shocks—just like any other business—and those things will affect us too; we’re holding to our guidance of finishing the year with profitable EBITDA and having a profitable 2026. There will be some bumps along the way that we'll work through. A sudden jolt in soybean oil could hurt us, though a reversal of that is — all our inputs in the biodiesel business are commodities; they're at record highs, so we'd expect them to begin returning toward more average levels, and that ought to help our business. We do have exposure to the oil and gas industry and the oil and gas complex. At the moment, the political climate is helping us to some degree — and should it persist for a longer stretch, we'd expect that to keep working in our favor. If instead it resolves and crude prices fall sharply, that might hit our business somewhat, correct? That's roughly the way to look at it.

Jeff Van Sinderen analyst
#15

You talked about building out what I suppose you'd call production cells for customers in the chemical business. I was just hoping you could give us a bit more detail on what you're seeing there. Have requests to build out those cells been picking up? What kind of timeline do those involve? And then how do you expect that to affect revenue and profitability, let's say over the coming year or so, for the chemical business?

Roeland Polet executive
#16

Well, there's one thing that's really positive about that business and one thing that can be frustrating, right? The good news is that once these are built out, they usually remain on the site and don't go away. The frustrating side is the lead times, right? It takes 1.5 to 2 years from kicking off the project to completing the engineering, beginning construction — we'd need to modify part of our plants, build it, and then start production. So I'd say you should figure on lead times of roughly 1.5 years to 2 years from a project's start to — and we do have projects in the pipeline right now, so not every project we're working on takes the full 2 years. And then once it's commercialized, right? Much of the capital is allocated by the customer to the projects, or we recover that capital over the life of a project. As for the life of a project, you should think of it as usually beginning around 3 years — 3-year contracts — and then they'll often run on to 5 to 6 years, if not longer; we have products we've been making here for 20 years under those kinds of contracts. But they take a little time to ramp up. There's an approval step, since it's their critical processes. Once they're ramped up, though, they tend to stay here.

Jeff Van Sinderen analyst
#17

All right, great. And then, I suppose, if we could pivot somewhat to the gross margin outlook. Is there any additional color or any sense you could provide regarding the gross margin outlook for the balance of the year? And then, on the whole, what kind of quarterly cadence do you expect for the remainder of the year, perhaps relative to Q2?

Roeland Polet executive
#18

When you say quarterly cadence, could you perhaps clarify that a bit?

Jeff Van Sinderen analyst
#19

Yeah, absolutely. I'm only attempting to get a feel for — I mean, your metrics were genuinely strong here. I'm just curious, do you figure we're likely to see growth on a sequential basis? Do you figure gross margins will go up more, just attempting to get a feel for whatever metrics we can without giving — without asking you for guidance, just any sense — so maybe to provide some color, right?

Roeland Polet executive
#20

So maybe to provide some color — let's turn to biofuels, right? So biofuels, we're running at margins above what we had anticipated yet. Our inputs stay highly elevated, right? So when you see announcements like I think it was ADM or cargo bringing on additional soybean crush capacity because there's a bit of a shortage in soybean oil, that's good news for us, right? So that at some point, needs to translate into lower unit cost or lower cost in soybean oil, right? A record harvest for soybeans that at some point will translate into lower input costs. So the margin levels that we enjoy today, we don't see anything on the horizon that will dramatically disrupt that; and then in biodiesel, the elements that drive that input cost on the biodiesel market would have you believe that there's going to be a reversion back to the mean. In terms of the cost; so there should be some upside, right? We don't have that in our numbers. We're not projecting that, but that's how we kind of think about it.

Roeland Polet executive
#21

Yes. Thank you all so much for taking an interest in FutureFuel. We think this is a great business we have here. We also feel that we should be more transparent with our investor base, and we plan to do that through investor presentations and additional calls. With that said, we look forward to welcoming you back on our Q3 call later in the year. Thank you.

Operator operator
#22

That brings us to the end of today's call. You're welcome to disconnect your lines now. Thanks once more for joining us.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete FutureFuel Corp. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to FutureFuel Corp. earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.